Amdocs reported fiscal Q4 and full-year 2026 results in line with guidance, but its fiscal 2027 outlook signals a major revenue and profit hit from its T-Mobile situation. Separately, several law firms launched securities fraud investigations, adding regulatory and legal headwinds that could weigh on the stock if facts suggest material misstatements or exposure.
Howard G. Smith's securities-fraud inquiry into Amdocs (DOX) follows the November 3, 2026 disclosure. While no formal action has been announced, the probe could affect sentiment and raise risk premiums if new facts emerge. Investors should monitor DOX disclosures, regulatory responses, and any potential settlements or penalties.
Amdocs (DOX) reported a Q4 miss with EPS of $1.98 (vs $1.99 expected) and revenue of $1.194 billion, guiding FY27 below consensus. The stock fell about 39% premarket to $38, signaling outsized negative sentiment and potential further downside as investors reassess growth and margins. The negative read may put near-term pressure on multiple-iteration software/IT services names until clearer visibility emerges.
Amdocs added to Dividend Growth Model Portfolio, highlighting dividend reliability and growth. Generated $2.9B FCF (2019–3Q25) versus $1.3B dividends paid, showing strong coverage. Quarterly dividend rose from $0.29 to $0.53; annualized yield ~2.5%. PEBV=1.0 implies zero NOPAT growth priced in; model scenario implies $98 fair value (17% upside).
Amdocs' Q4 earnings report set for Nov. 11, predicting $1.82 per share. Quarterly revenue expected at $1.15 billion, down from $1.26 billion last year. Signed multi-year agreement for enhanced managed transformation using AI offerings. Shares rose 1.1% to close at $85.49 recently. Several analysts maintain positive ratings despite slight changes in price targets.